[Summery]  The first target is tau protein, which is known to influence the development of several degenerative brain diseases, including frontal dementia and Alzheimer's disease. PeopleBio and Absolology will first begin developing a blood-based diagnostic kit that measures tau protein, an important factor in Alzheimer's disease. It also plans to jointly develop upgraded products in the beta amyloid field. 

http://www.bokuennews.com/news/article.html?no=199525

Excerpt from bokuennews